CN Patent

CN105997993B — 一种用于心血管疾病治疗的固体口服型制剂及其制备方法

Assigned to Mai Lifang · Expires 2018-03-30 · 8y expired

What this patent protects

本发明提供了一种稳定的固体口服型制剂，该固体口服型制剂含水量、杂质1及总杂含量在特定范围内，综合使得所述制剂具有储存稳定性高的特点，较现有技术公开的制剂更符合工业化生产及临床使用。

USPTO Abstract

本发明提供了一种稳定的固体口服型制剂，该固体口服型制剂含水量、杂质1及总杂含量在特定范围内，综合使得所述制剂具有储存稳定性高的特点，较现有技术公开的制剂更符合工业化生产及临床使用。

Drugs covered by this patent

Patent Metadata

Patent number: CN105997993B
Jurisdiction: CN
Classification: —
Expires: 2018-03-30
Drug substance claim: No
Drug product claim: No
Assignee: Mai Lifang
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.